These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 673744)

  • 21. [Treatment of familial hypercholesterolemia - hyperlipoproteinemia type II with anion exchange resins].
    Kusić M; Gavrilović M; Mihajlović M; Bosković B
    Vojnosanit Pregl; 1981; 38(1):23-7. PubMed ID: 7245659
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colestipol plus fenofibrate versus synvinolin in familial hypercholesterolaemia.
    Weisweiler P; Schwandt P
    Lancet; 1986 Nov; 2(8517):1212-3. PubMed ID: 2877340
    [No Abstract]   [Full Text] [Related]  

  • 24. [The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
    Forti N; Dereviacki BE; Giannini SD
    Arq Bras Cardiol; 1988 Jul; 51(1):49-53. PubMed ID: 3073736
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans.
    Konzem SL; Gray DR; Kashyap ML
    Pharmacotherapy; 1997; 17(3):576-83. PubMed ID: 9165562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Colestipol by hypercholesteremia in diabetics].
    Düntsch G
    Fortschr Med; 1977 Jun; 95(22):1492-6. PubMed ID: 873435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adrenocortical functions in hypercholesterolemic patients; effect of long-term treatment with colestipol-HCl (author's transl)].
    Morimoto Y
    Horumon To Rinsho; 1981 Feb; 29(2):237-43. PubMed ID: 7261445
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combined therapy of hyperlipoproteinemia. Colestipol and gemfibrozil in the treatment of heterozygous familial hypercholesterolemia].
    Ceska R; Sobra J; Toschnerová H; Traurig J
    Cas Lek Cesk; 1992 Mar; 131(6):183-5. PubMed ID: 1586935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experiences with a new cholesterolemia-lowering resin, Colestipol (U-26, 597 A. Upjohn)].
    Muls E; Lemmens P
    Acta Clin Belg; 1975; 30(5):409-14. PubMed ID: 1221747
    [No Abstract]   [Full Text] [Related]  

  • 31. Colestipol therapy and selected vitamin and mineral levels in children.
    Nutr Rev; 1980 Jul; 38(7):236-7. PubMed ID: 7422147
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of encapsulated, low-dose colestipol in patients with hyperlipidemia.
    Linet OI; Grzegorczyk CR; Demke DM
    J Clin Pharmacol; 1988 Sep; 28(9):804-6. PubMed ID: 3230147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study.
    Ruoff G
    J Am Geriatr Soc; 1978 Mar; 26(3):121-6. PubMed ID: 624819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile acid sequestrants and cholesterol.
    Schon P
    N Z Med J; 1990 Apr; 103(887):163. PubMed ID: 2111529
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiography for study of lipid-lowering therapy.
    Blankenhorn DH; Sanmarco ME
    Circulation; 1979 Feb; 59(2):212-4. PubMed ID: 758988
    [No Abstract]   [Full Text] [Related]  

  • 36. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
    Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
    Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G; Cazzani E; Romanò M; Muzio L
    Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643
    [No Abstract]   [Full Text] [Related]  

  • 38. Cochleovestibular disorders and hyperlipidemia. A controlled trial with fenofibrate.
    Torossian F; Laredo C
    Monogr Atheroscler; 1986; 14():222-9. PubMed ID: 3526130
    [No Abstract]   [Full Text] [Related]  

  • 39. [Advances in pharmacotherapy of arteriosclerosis].
    Balewska K; Witanowska A
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):103-7. PubMed ID: 2216947
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
    Sznajderman M
    Przegl Lek; 1984; 41(7):493-9. PubMed ID: 6390536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.